NCT02111941 2025-10-31
Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
Clinical Trials
9 trialsNCT02042430 2024-12-13
Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Completed
NCT02728830 2024-02-21
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Duke University
Phase EARLY_PHASE1 Completed
NCT02316834 2022-02-24
POSITION
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT03297489 2021-10-06
Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT01670799 2020-02-27
Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer
New Mexico Cancer Research Alliance
Phase EARLY_PHASE1 Completed
NCT01504126 2019-08-29
Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT01747798 2019-08-02
Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT01626014 2015-12-02
Interactive Educational Website for Women With Ovarian Cancer & Caregivers
University of Minnesota
Phase EARLY_PHASE1 Completed